At an apple processing facility in Watsonville, the 2025 UC Santa Cruz iGEM team took a deep dive into mycotoxins in food, ...

Twist Bioscience (TWST) just rolled out research grade Plasmid DNA Preps tailored for pre clinical pharma and biotech work, a small but telling move that helps explain the recent uptick in the stock.

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched research-grade ...

Piper Sandler 37th Annual Healthcare Conference December 2, 2025 8:30 AM ESTCompany ParticipantsJacqueline Shea - ...

Joshua Lederberg, Nobel laureate and president of Rockefeller University, is well known in biology circles. Not so his wife, ...

TriLink BioTechnologies senior scientist Dr Cody Palumbo discusses the blockers to manufacturing mRNA-based gene editing ...

The post Her Coworker Thought They Were Better Than Her, So She Decided To Get Revenge In The Best Possible Way first on ...

Plasmid Purification Market to reach USD 6.6 Bn by 2035 at 12.3% CAGR, Driven by rising gene therapy demand, mRNA vaccines, ...

The bill, sponsored by Sen. Tom Corbin, would require providers to inform patients that the vaccine is “novel,” that it “may be contaminated by the presence of fragments of bacterial plasmid DNA ...

Investing.com -- Genenta Science (NASDAQ:GNTA) stock soared 241.8% in premarket trading Friday after announcing a strategic collaboration with ANEMOCYTE focused on off-the-shelf lentiviral vector ...

VectorBuilder, a global leader in gene delivery technologies and CDMO services, today announced the publication of the miniVec plasmid system, engineered for safer, more efficient, and more scalable ...